We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
2023-2028 Anti-Rejection Drugs Immunosuppressants China Outlook
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 68 days · 68 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 68 days • 1 price levels
Price Analysis
Most common price: £495 (68 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 68 days
Description
Key Features
ICON Group International market research report covering anti-rejection drugs and immunosuppressants for liver disease treatments in China.
Comprehensive 2023-2028 outlook period providing five-year market forecasts and trend analysis for Chinese pharmaceutical development.
Market dynamics analysis including competitive landscape, pricing strategies, and growth opportunities for liver disease pharmaceutical interventions.
Strategic insights for pharmaceutical professionals, healthcare analysts, and industry stakeholders evaluating China's immunosuppressive therapy market.
Product Specifications
- Format
- paperback
- ASIN
- B0BBK3KFXP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 24 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Antiviral Drugs in China
The 2023-2028 Outlook for Topical Pigmentation Disorders Treatment Drugs in China
The 2023-2028 Outlook for Iron Drugs in China
The 2023-2028 Outlook for Oligonucleotide Therapeutics in China
The 2023-2028 Outlook for Renal Anemia Treatments in China
2023-2028 Biologic Vasculitis Treatments Outlook - China Market
The 2023-2028 Outlook for Anti-Epileptic Drugs in China
2023-2028 Outlook for IBS Treatments in China - Market Report
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in China
The 2023-2028 Outlook for Osteoarthritis Treatments in China
The 2023-2028 Outlook for Alcohol Addiction Treatments in China
The 2023-2028 Outlook for Children's Digestion Medicines in China
The 2023-2028 Outlook for Corneal Ulcer Treatments in China
The 2023-2028 Outlook for Lipids in China
The 2023-2028 Outlook for Bronchitis Treatments in China
The 2023-2028 Outlook for Persistent Corneal Epithelial Defects Treatments in China
The 2023-2028 Outlook for Chronic Obstructive Pulmonary Disease Treatments in China
2023-2028 Outlook for Subcutaneous Immunoglobin in China
The 2023-2028 Outlook for Allergic Rhinitis Treatments in China
The 2023-2028 Outlook for Kidney Function Tests in China
The 2023-2028 Outlook for Food Antioxidants in China
The 2023-2028 Outlook for Laser Therapies in China
The 2023-2028 Outlook for Hormone-Drug Breast Cancer Therapeutics in China
